Parnax Lab Limited (BOM:506128)

India flag India · Delayed Price · Currency is INR
128.60
-1.10 (-0.85%)
At close: Mar 9, 2026
37.81%
Market Cap 1.49B
Revenue (ttm) 2.28B
Net Income (ttm) 125.20M
Shares Out 11.49M
EPS (ttm) 10.90
PE Ratio 11.93
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,886
Average Volume 6,754
Open 131.30
Previous Close 129.70
Day's Range 121.00 - 131.30
52-Week Range 85.60 - 145.00
Beta -0.07
RSI 53.29
Earnings Date Feb 13, 2026

About Parnax Lab

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provid... [Read more]

Industry Pharmaceutical Preparations
Founded 1982
Employees 12
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506128
Full Company Profile

Financial Performance

In fiscal year 2025, Parnax Lab's revenue was 1.88 billion, a decrease of -0.54% compared to the previous year's 1.89 billion. Earnings were 115.19 million, an increase of 19.87%.

Financial Statements

News

There is no news available yet.